Dystrophin gene muscle promoter (M-promoter) (M-promoter)

The dystrophin gene muscle promoter, also known as the M-promoter, is a tissue-specific regulatory element located upstream of the first exon of the DMD gene, driving high-level expression of the full-length dystrophin transcript primarily in skeletal muscle and cardiomyocytes, with lower levels in certain brain glial cells. It contains key cis-acting sequences such as a CArG box at -91 bp, myocyte-specific enhancer-binding nuclear factor 1 sites, a muscle-CAAT consensus, an ATA box, and GC box, which enable muscle-specific transcription starting 37 bp upstream of the published cDNA sequence. At least 149-850 bp of upstream sequence is sufficient for directing muscle-specific expression of reporter genes like chloramphenicol acetyltransferase in myogenic cells. This promoter ensures dystrophin protein production, which anchors the cytoskeleton to the extracellular matrix via the dystrophin-associated protein complex, stabilizing muscle fibers during contraction and preventing injury. Mutations affecting the M-promoter, such as those selectively impairing cardiac expression, contribute to X-linked dilated cardiomyopathy without skeletal muscle involvement, while broader DMD gene mutations disrupt dystrophin and cause progressive muscle degeneration in Duchenne and Becker muscular dystrophies. Although not a direct therapeutic target like receptors or enzymes, its role in dystrophin expression makes it relevant for gene therapy strategies aiming to restore muscle-specific transcription.

Other names

muscle-specific promoterM promoter